Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cytokine pathways and joint inflammation in rheumatoid arthritis.

× No keyword cloud information.

562 in total

Review 1. Adalimumab (a fully human anti-tumour necrosis factor alpha monoclonal antibody) in the treatment of active rheumatoid arthritis: the initial results of five trials.

Authors: R Rau
Journal: Ann Rheum Dis Date: 2002-11 Impact factor: 19.103

Review 2. Structure and function of interleukin-22 and other members of the interleukin-10 family.

Authors: Daniela Barretto Barbosa Trivella; José Ribamar Ferreira-Júnior; Laure Dumoutier; Jean-Christophe Renauld; Igor Polikarpov
Journal: Cell Mol Life Sci Date: 2010-05-08 Impact factor: 9.261

3. Anti-inflammatory activities of light emitting diode irradiation on collagen-induced arthritis in mice (a secondary publication).

Authors: Noboru Kuboyama; Mitsuhiro Ohta; Yusuke Sato; Yoshimitsu Abiko
Journal: Laser Ther Date: 2014-09-30

Review 4. Phytochemicals as potential antidotes for targeting NF-κB in rheumatoid arthritis.

Authors: R Kowshik Aravilli; S Laveen Vikram; V Kohila
Journal: 3 Biotech Date: 2017-07-18 Impact factor: 2.406

5. Peripheral soluble epoxide hydrolase inhibition reduces hypernociception and inflammation in albumin-induced arthritis in temporomandibular joint of rats.

Authors: Juliana Maia Teixeira; Henrique Ballassini Abdalla; Rosanna Tarkany Basting; Bruce D Hammock; Marcelo Henrique Napimoga; Juliana Trindade Clemente-Napimoga
Journal: Int Immunopharmacol Date: 2020-07-28 Impact factor: 4.932

6. Nonresolving inflammation in gp91phox-/- mice, a model of human chronic granulomatous disease, has lower adenosine and cyclic adenosine 5'-monophosphate.

Authors: Ravindra Rajakariar; Justine Newson; Edwin K Jackson; Precilla Sawmynaden; Andrew Smith; Farooq Rahman; Muhammad M Yaqoob; Derek W Gilroy
Journal: J Immunol Date: 2009-03-01 Impact factor: 5.422

7. Plasminogen activator inhibitor-1 C/G polymorphism in relation to plasma levels in rheumatoid arthritis.

Authors: Norma Torres-Carrillo; Nora Magdalena Torres-Carrillo; Gloria Esther Martínez-Bonilla; Mónica Vázquez-Del Mercado; Claudia Azucena Palafox-Sánchez; Edith Oregón-Romero; Ana Guilaisne Bernard-Medina; Héctor Rangel-Villalobos; José Francisco Muñoz-Valle
Journal: Clin Exp Med Date: 2009-02-24 Impact factor: 3.984

Review 8. Efficacy, tolerability and cost effectiveness of disease-modifying antirheumatic drugs and biologic agents in rheumatoid arthritis.

Authors: Michael T Nurmohamed; Ben A C Dijkmans
Journal: Drugs Date: 2005 Impact factor: 9.546

9. Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more.

Authors: Martin O Judex; Barbara M Mueller
Journal: Am J Pathol Date: 2005-03 Impact factor: 4.307

10. Infliximab has no apparent effect in the inner ear hearing function of patients with rheumatoid arthritis and ankylosing spondylitis.

Authors: H Toktas; E Okur; U Dundar; A Dikici; O K Kahveci
Journal: Clin Rheumatol Date: 2014-04-27 Impact factor: 2.980